Influence of interferon therapy on signal-averaged and ambulatory electrocardiograms in patients with chronic active hepatitis

Shin Ichi Hiramatsu, Toru Maruyama, Hiroyuki Ito, Shinji Shimoda, Yoshikazu Kaji, Mine Harada

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Although interferon (IFN) shows cardiotoxicity and arrhythmogenesis, the influence of IFN on signal-averaged electrocardiography remains to be clarified. The aim of this study was to test a clinical hypothesis that IFN therapy for hepatitis C virus may induce ventricular late potentials (LPs) and related arrhythmias in patients with chronic active hepatitis. Signal-averaged and ambulatory electrocardiograms were recorded sequentially in patients with chronic active hepatitis C (n = 22) throughout the entire period of IFN therapy. The filtered QRS duration (fQRS) and low amplitude (< 40 μV) signal duration (LAS40) were significantly increased (95.5 ± 8.5 to 99.6 ± 9.4 msec, P < 0.0001, and 32.8 ± 3.1 to 36.3 ± 3.0 msec, P < 0.0001, respectively), whereas the root mean square voltage in the terminal 40 msec of the fQRS (RMS40) was significantly decreased (25.5 ± 5.4 to 22.3 ± 5.2 μV, P < 0.005) 1 month after starting the IFN therapy. The ventricular LP was negative in all subjects before starting therapy, but became positive in 7 patients after the therapy commenced. There were no differences in clinical baseline characteristics between the LP-positive (n = 7) and LP-negative (n = 15) groups. Significant increases in mean heart rate, fQRS, and LAS40 were observed after starting the therapy, irrespective of the appearance of the ventricular LP, whereas a decrease in RMS40 was observed only in the LP-positive group. No sustained ventricular arrhythmias were documented in the ambulatory electrocardiography and no cardiac events were encountered in the follow-up period. Therefore, the results indicate a reversible and subclinical risk of IFN-induced arrhythmogenesis.

Original languageEnglish
Pages (from-to)1033-1040
Number of pages8
JournalInternational heart journal
Volume46
Issue number6
DOIs
Publication statusPublished - Dec 1 2005

Fingerprint

Chronic Hepatitis
Interferons
Electrocardiography
Cardiac Arrhythmias
Therapeutics
Ambulatory Electrocardiography
Chronic Hepatitis C
Hepacivirus
Heart Rate

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Influence of interferon therapy on signal-averaged and ambulatory electrocardiograms in patients with chronic active hepatitis. / Hiramatsu, Shin Ichi; Maruyama, Toru; Ito, Hiroyuki; Shimoda, Shinji; Kaji, Yoshikazu; Harada, Mine.

In: International heart journal, Vol. 46, No. 6, 01.12.2005, p. 1033-1040.

Research output: Contribution to journalArticle

@article{60f15143b332407d936b97179a210bde,
title = "Influence of interferon therapy on signal-averaged and ambulatory electrocardiograms in patients with chronic active hepatitis",
abstract = "Although interferon (IFN) shows cardiotoxicity and arrhythmogenesis, the influence of IFN on signal-averaged electrocardiography remains to be clarified. The aim of this study was to test a clinical hypothesis that IFN therapy for hepatitis C virus may induce ventricular late potentials (LPs) and related arrhythmias in patients with chronic active hepatitis. Signal-averaged and ambulatory electrocardiograms were recorded sequentially in patients with chronic active hepatitis C (n = 22) throughout the entire period of IFN therapy. The filtered QRS duration (fQRS) and low amplitude (< 40 μV) signal duration (LAS40) were significantly increased (95.5 ± 8.5 to 99.6 ± 9.4 msec, P < 0.0001, and 32.8 ± 3.1 to 36.3 ± 3.0 msec, P < 0.0001, respectively), whereas the root mean square voltage in the terminal 40 msec of the fQRS (RMS40) was significantly decreased (25.5 ± 5.4 to 22.3 ± 5.2 μV, P < 0.005) 1 month after starting the IFN therapy. The ventricular LP was negative in all subjects before starting therapy, but became positive in 7 patients after the therapy commenced. There were no differences in clinical baseline characteristics between the LP-positive (n = 7) and LP-negative (n = 15) groups. Significant increases in mean heart rate, fQRS, and LAS40 were observed after starting the therapy, irrespective of the appearance of the ventricular LP, whereas a decrease in RMS40 was observed only in the LP-positive group. No sustained ventricular arrhythmias were documented in the ambulatory electrocardiography and no cardiac events were encountered in the follow-up period. Therefore, the results indicate a reversible and subclinical risk of IFN-induced arrhythmogenesis.",
author = "Hiramatsu, {Shin Ichi} and Toru Maruyama and Hiroyuki Ito and Shinji Shimoda and Yoshikazu Kaji and Mine Harada",
year = "2005",
month = "12",
day = "1",
doi = "10.1536/ihj.46.1033",
language = "English",
volume = "46",
pages = "1033--1040",
journal = "International Heart Journal",
issn = "1349-2365",
publisher = "International Heart Journal Association",
number = "6",

}

TY - JOUR

T1 - Influence of interferon therapy on signal-averaged and ambulatory electrocardiograms in patients with chronic active hepatitis

AU - Hiramatsu, Shin Ichi

AU - Maruyama, Toru

AU - Ito, Hiroyuki

AU - Shimoda, Shinji

AU - Kaji, Yoshikazu

AU - Harada, Mine

PY - 2005/12/1

Y1 - 2005/12/1

N2 - Although interferon (IFN) shows cardiotoxicity and arrhythmogenesis, the influence of IFN on signal-averaged electrocardiography remains to be clarified. The aim of this study was to test a clinical hypothesis that IFN therapy for hepatitis C virus may induce ventricular late potentials (LPs) and related arrhythmias in patients with chronic active hepatitis. Signal-averaged and ambulatory electrocardiograms were recorded sequentially in patients with chronic active hepatitis C (n = 22) throughout the entire period of IFN therapy. The filtered QRS duration (fQRS) and low amplitude (< 40 μV) signal duration (LAS40) were significantly increased (95.5 ± 8.5 to 99.6 ± 9.4 msec, P < 0.0001, and 32.8 ± 3.1 to 36.3 ± 3.0 msec, P < 0.0001, respectively), whereas the root mean square voltage in the terminal 40 msec of the fQRS (RMS40) was significantly decreased (25.5 ± 5.4 to 22.3 ± 5.2 μV, P < 0.005) 1 month after starting the IFN therapy. The ventricular LP was negative in all subjects before starting therapy, but became positive in 7 patients after the therapy commenced. There were no differences in clinical baseline characteristics between the LP-positive (n = 7) and LP-negative (n = 15) groups. Significant increases in mean heart rate, fQRS, and LAS40 were observed after starting the therapy, irrespective of the appearance of the ventricular LP, whereas a decrease in RMS40 was observed only in the LP-positive group. No sustained ventricular arrhythmias were documented in the ambulatory electrocardiography and no cardiac events were encountered in the follow-up period. Therefore, the results indicate a reversible and subclinical risk of IFN-induced arrhythmogenesis.

AB - Although interferon (IFN) shows cardiotoxicity and arrhythmogenesis, the influence of IFN on signal-averaged electrocardiography remains to be clarified. The aim of this study was to test a clinical hypothesis that IFN therapy for hepatitis C virus may induce ventricular late potentials (LPs) and related arrhythmias in patients with chronic active hepatitis. Signal-averaged and ambulatory electrocardiograms were recorded sequentially in patients with chronic active hepatitis C (n = 22) throughout the entire period of IFN therapy. The filtered QRS duration (fQRS) and low amplitude (< 40 μV) signal duration (LAS40) were significantly increased (95.5 ± 8.5 to 99.6 ± 9.4 msec, P < 0.0001, and 32.8 ± 3.1 to 36.3 ± 3.0 msec, P < 0.0001, respectively), whereas the root mean square voltage in the terminal 40 msec of the fQRS (RMS40) was significantly decreased (25.5 ± 5.4 to 22.3 ± 5.2 μV, P < 0.005) 1 month after starting the IFN therapy. The ventricular LP was negative in all subjects before starting therapy, but became positive in 7 patients after the therapy commenced. There were no differences in clinical baseline characteristics between the LP-positive (n = 7) and LP-negative (n = 15) groups. Significant increases in mean heart rate, fQRS, and LAS40 were observed after starting the therapy, irrespective of the appearance of the ventricular LP, whereas a decrease in RMS40 was observed only in the LP-positive group. No sustained ventricular arrhythmias were documented in the ambulatory electrocardiography and no cardiac events were encountered in the follow-up period. Therefore, the results indicate a reversible and subclinical risk of IFN-induced arrhythmogenesis.

UR - http://www.scopus.com/inward/record.url?scp=30444457728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30444457728&partnerID=8YFLogxK

U2 - 10.1536/ihj.46.1033

DO - 10.1536/ihj.46.1033

M3 - Article

C2 - 16394599

AN - SCOPUS:30444457728

VL - 46

SP - 1033

EP - 1040

JO - International Heart Journal

JF - International Heart Journal

SN - 1349-2365

IS - 6

ER -